Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:26 PM
Ignite Modification Date: 2025-12-24 @ 5:26 PM
NCT ID: NCT06691568
Eligibility Criteria: Inclusion Criteria: * Subjects who signed the written informed consent * Men or women aged between 18- and 65-year-old * Subjects covered by health social identification number * Subjects able to understand and complete study-related procedures * Subjects reported history of symptomatic cat allergen-triggered asthma (GINA1-2) with or without associated allergic rhinitis and/or conjunctivitis * Positive skin prick test (SPT) with cat hair extract with mean wheal diameter ≥ 5 mm compared to negative control (NaCl reaction \< 2 mm) * Subjects with FEV1≥70% predicted at screening and before allergen exposure, * Subjects with at least one drop in FEV1 ≥ 20% within the 2- hours exposure at baseline (V2) * Women of childbearing potential with a negative pregnancy test throughout the study period and highly effective contraception: oral contraceptives, condom with spermicide, intrauterine device, bilateral tubal ligation, vasectomized partner. Exclusion Criteria: * Allergen immunotherapy to cat allergen for more than 1 month in the 3 years prior to the screening visit * Ongoing allergen immunotherapy to another allergen * History of anaphylactic reactions to cat allergen exposure or cat allergen immunotherapy * History of anaphylactic reactions to another allergen in the last 6 weeks before inclusion * Nasal polyposis, deviation of nasal septum, or diagnosis of uncontrolled non- allergic rhinitis * Subjects allergic to indoor environmental allergens (molds, house dust mite allergens) with obvious exposure to these allergens causing allergic symptoms * No cat exposure at home for the past year and must continue having no exposure at home during the study; cat exposure outside of the home shall be avoided for at least one week prior to any Cat Allergen Challenge * Subjects with pollen season allergies (birch, grass, ash) will not be able to participate in the study during the pollen season for these allergens * Conjunctival diseases such as severe keratitis, or other ocular disorders, ocular pain and/or photophobia during pollen season * Moderate to severe asthma GINA 3 to 5
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT06691568
Study Brief:
Protocol Section: NCT06691568